Skip to content
Screener

Baxter International BAX Pharmaceuticals — Currency translation and other

Other segment segments

Medical Products & Therapies
$80M+243%
Healthcare Systems & Technologies
$22M+257%

Similar metrics at other companies

Air Products and Chemicals logo
APDCorporate And Other — Currency translation
$100K-66.7%
Raytheon Technologies logo
RTXRaytheon — Foreign Currency Translation and Other
-$1M-200%
Johnson Controls International logo
JCIAmericas — Foreign currency translation and other
-$26M
Johnson Controls International logo
JCIAPAC — Foreign currency translation and other
$5M
Johnson Controls International logo
JCIEMEA — Foreign currency translation and other
-$110M
Penske Automotive Group logo
PAGOther — Foreign currency translation
$1.3M+179%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments.

The source filing: Baxter International’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 4:46 PM EST
Fiscal year
FY2025
Accession
0001628280-26-007733
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
December 31, 2023$1,241$3,989$563$5,793
Impairments(425)(425)
Currency translation and other(56)(14)(23)(93)
December 31, 2024$1,185$3,550$540$5,275
Impairments(485)(485)
Currency translation and other802237139
December 31, 2025$1,265$3,087$577$4,929

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Baxter International's pharmaceuticals — currency translation and other?
Baxter International (BAX) reported pharmaceuticals — currency translation and other of $9.25M in Q4 2025.
How has Baxter International's pharmaceuticals — currency translation and other changed year-over-year?
Baxter International's pharmaceuticals — currency translation and other increased by 260.9% year-over-year, from -$5.75M to $9.25M.
What does pharmaceuticals — currency translation and other mean?
This metric represents the net impact of foreign exchange rate fluctuations and miscellaneous non-operating adjustments on the reported financial results of the Pharmaceuticals segment. It captures gains or losses arising from the conversion of foreign-denominated transactions into the reporting currency, alongside minor non-recurring items. Monitoring this helps isolate the underlying operational performance of the segment from external macroeconomic volatility.

Ask your AI about Baxter International's pharmaceuticals — currency translation and other.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude